BOLD Capital Partners

Bold Capital Partners, established in 2015, is a venture capital firm headquartered in Santa Monica, California, with an additional office in Los Altos. The firm specializes in early-stage and growth capital investments, focusing primarily on technology companies within the health & life sciences and deep tech & productivity sectors.

Emilio Diez Barroso

General Partner

Neal Bhadkamkar

General Partner

Will Borthwick

Principal

Teymour Boutros-Gali

Managing Partner

Maxx Bricklin

Partner

Peter Diamandis

General Partner

Matthew Grob

Venture Partner

Felicia Hsu MD

Principal

Neil Jacobstein

Venture Partner

William Meeker

CFO

Henry Shi

Venture Partner

Ysette Witteveen

Partner

Mignon Xu

Associate

Helen McBride Ph.D

Operating Partner

97 past transactions

Near Space Labs

Series B in 2025
Near Space Labs is an aerial imagery and earth observation company based in the United States that specializes in providing high-quality geospatial information for various sectors. The company offers cloud-based delivery of fully processed images through its API, facilitating easy monitoring of assets across broad or specific areas. Near Space Labs supports businesses, government organizations, and partners by delivering actionable insights that enhance remote sensing capabilities. Its services are utilized in diverse fields, including insurance, utilities, infrastructure, conservation, smart cities, retail, energy, and disaster response. By monitoring construction progress and addressing issues such as pipeline leaks, vegetation encroachment, and weather-related damage, Near Space Labs enables clients to improve mobility, leisure, and urban planning.

Chef Robotics

Series A in 2025
Chef Robotics is a robotics and artificial intelligence company serving the food industry, founded in 2019 and headquartered in San Francisco. It develops AI-enabled robotic automation for food manufacturing, integrating modular hardware and adaptive software with computer vision to handle variability in food products, automate assembly processes, and optimize labor productivity. Its solutions aim to reduce waste, improve consistency, and address workforce shortages through intelligent automation.

Esperto Medical

Series A in 2024
Esperto Medical is a medical device company based in Irvine, California, focused on developing advanced wearable diagnostics for both hospital and remote patient monitoring. The company utilizes innovative resonance sonomanometry technology, which employs acoustic stimulation to provide continuous and noninvasive blood pressure measurements without the need for calibration. By enabling round-the-clock monitoring of vital signs, Esperto Medical’s devices aim to enhance accessibility to medical care through automation, allowing patients to effectively manage their health from home or within clinical settings.

Feno

Seed Round in 2024
Feno is a pioneering oral health company that aims to improve overall health by addressing oral health issues. It develops innovative, tech-driven products such as the 20-second Feno Smartbrush, an at-home oral scanner, and AI-powered digital oral health coaches. These solutions, which leverage advanced technologies and proprietary formulations, empower individuals to take control of their oral health, thereby potentially reducing the risk of systemic health conditions like heart disease, stroke, and diabetes.

Discure

Series A in 2024
Discure Technologies is focused on developing a minimally invasive, implantable bioelectronic device aimed at treating degenerative disc disease (DDD). The company employs a novel bioelectric technique that targets the root causes of DDD, facilitating the healing of damaged discs, alleviating pain, and restoring normal function for patients. Through its innovative approach, Discure seeks to provide effective solutions for individuals suffering from this debilitating condition.

Viome Life Sciences

Series D in 2024
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.

Openwater

Venture Round in 2024
Openwater is a medical technology startup founded in 2016 and based in San Francisco, California. The company specializes in developing advanced wearable devices that utilize novel optoelectronics to achieve MRI-like resolution for medical diagnostics and treatments. By employing LCDs with small pixels, Openwater's technology creates holographic images that reduce scattering, enabling physicians to visualize the inner workings of the body and brain at a cellular level. This innovation allows for precise diagnosis and targeted treatment of diseases by manipulating or destroying individual cells without damaging surrounding tissue. Openwater aims to revolutionize medical imaging and improve patient outcomes through its cutting-edge approach.

Immunis

Venture Round in 2024
Immunis is a private biotechnology company focused on addressing age and disease-related immune decline through innovative stem cell-derived therapies. The company specializes in utilizing human stem cells to create specific populations of cells that secrete therapeutic factors. This approach aims to enable healthcare professionals to enhance immune system development, modulation, and overall health in patients. By harnessing the potential of stem cell technology, Immunis seeks to offer novel treatment options that can improve immune function and combat the effects of aging and various diseases.

Holoclara

Series A in 2024
Holoclara is an immunotherapy company focused on providing innovative solutions for individuals suffering from autoimmune disorders. The company specializes in delivering nematode-derived molecules known for their therapeutic properties. By identifying and developing these molecules from various worm species, Holoclara aims to create safe, orally available therapeutics that can improve the quality of life for patients. Through its targeted approach, Holoclara seeks to bring relief and promote overall health and well-being for those affected by autoimmune conditions.

Lucidity

Seed Round in 2024
Lucidity is a multi-cloud storage management platform that optimizes storage across AWS, Azure, and Google Cloud. The platform automates cloud infrastructure management by dynamically adjusting block storage in real time, which eliminates downtime and enhances application performance. By streamlining storage operations, Lucidity enables enterprises to significantly reduce cloud costs by up to 70% while ensuring consistent and reliable performance. This approach allows clients to effectively manage their storage resources based on their data requirements, leading to improved operational efficiency and predictable performance.

Synadia Communications

Series B in 2024
Synadia Communications develops and maintains NATS.io, an open-source messaging system designed for cloud-native applications, microservices architectures, IoT, and other distributed systems. Founded in 2017, the company offers commercial support, consulting services, and training around its technology.

Gallant Therapeutics

Series A in 2024
Gallant Therapeutics is an animal health biotechnology company developing allogeneic, "off-the-shelf" stem cell therapies from their stem cell platform. Gallant is also the leading provider of non-invasive stem cell banking during the spay or neuter process, opening the door to novel regenerative medical treatments formerly unavailable for non-human family members. Clinical studies demonstrate stem cell therapies help pets with a multitude of ailments, including osteoarthritis, atopic dermatitis, chronic kidney disease, and chronic stomatitis, among others. Gallant's first product helps to save cats that would die of chronic gingivostomatitis, with a robust pipeline in development for companion animals.

Mighty Buildings

Series B in 2023
Founded in 2017, Mighty Buildings is a pioneering construction technology company based in San Francisco. It specializes in manufacturing custom houses using proprietary 3D printing techniques, aiming to revolutionize the residential housing market by reducing waste and enhancing energy efficiency.

Viome Life Sciences

Series C in 2023
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.

Solarea Bio

Series B in 2023
Solarea Bio is a biotechnology company that develops microbial therapeutics derived from healthy food sources. It uses computational approaches to create synergistic combinations of bacteria, fungi, and prebiotic fibers with anti-inflammatory properties, targeting chronic health conditions such as osteopenia and osteoporosis in postmenopausal women.

Colossal Biosciences

Series B in 2023
Colossal Biosciences is a bioscience and genetic engineering company focused on restoring extinct species and protecting endangered ones. Leveraging gene editing technologies, including CRISPR, it pursues de-extinction initiatives such as reviving the woolly mammoth and aims to aid ecosystem restoration and biodiversity. The company develops technologies to revive species and repopulate ecosystems critical to environmental health and future human needs.

Dreamscape Learn

Series A in 2023
Dreamscape Learn is an edtech company focusing on cinematic story-telling, cutting-edge immersive technologies, and advanced pedagogy. They believe that the best educational designs combine multiple pedagogical modalities. Students study; they apply knowledge and concepts; they learn by doing and do in order to learn; they learn through text, lecture, visual and audio media, hands-on experience, and from one another. They create programs and products that connect all of these modes of engagement.

Syntis Bio

Venture Round in 2023
Syntis Bio is a late-stage preclinical company developing novel oral therapies targeting specific tissues. Its drug formulations aim to enhance bioavailability, focusing on treatments for obesity, diabetes, and rare diseases.

Deciduous Therapeutics

Seed Round in 2022
Deciduous Therapeutics is a biotechnology company focused on developing innovative immune-modulatory therapies aimed at addressing age-related diseases. The company specializes in creating novel molecules that activate the body's natural immune surveillance mechanisms to selectively eliminate senescent cells, which are associated with various age-related conditions. Led by Anil Bhushan, a professor at UCSF, and Robin Mansukhani, an experienced biotech entrepreneur, Deciduous Therapeutics is dedicated to promoting a healthier lifespan through its pioneering approach to therapeutics in the aging sector.

Earth Force Technologies

Seed Round in 2022
Earth Force Technologies develops a platform for managing vegetation in forests and plantations. Their system uses precision GPS, field sensors, remote-controlled machines, fire monitoring, and spot-fire suppression to help clients protect and manage forest vegetation effectively.

Viome Life Sciences

Series C in 2022
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.

Gameto

Venture Round in 2022
Gameto is a biotechnology company focused on advancing female reproductive health through innovative therapies. Recognizing the significant lack of treatment options in this underserved area, Gameto employs cutting-edge scientific techniques to develop solutions that enhance the quality of life for women. The company utilizes cellular engineering to create a platform that produces engineered ovarian and endometrial cell lines capable of mimicking the functions of natural cells, including hormone production and response. This platform underpins a portfolio of cellular therapeutics aimed at addressing various female reproductive diseases. Gameto's first initiative, Fertilo, targets improvements in in vitro fertilization (IVF) and egg freezing processes, striving to make them shorter, safer, and more effective. Additionally, the company is developing Deovo, an organoid model of the female reproductive system, and Ameno, a cell-based therapy designed to mitigate health issues related to primary ovarian insufficiency and menopause. Through these efforts, Gameto aims to transform the landscape of female reproductive health care.

KeyCare

Series A in 2022
KeyCare is a virtual care platform that leverages the Epic system to support health systems in enhancing patient access and quality of care. The platform is designed to provide a tech-driven virtual care team that supplements existing healthcare workforces, thereby broadening the options available for virtual care. By focusing on increasing accessibility and improving care quality, KeyCare aims to meet the needs of patients and healthcare providers in a rapidly evolving healthcare landscape.

AliveCor

Series F in 2022
AliveCor, Inc. specializes in developing digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile technology. The company's flagship product, KardiaMobile, is a personal mobile EKG device that provides instant detection of common heart arrhythmias, along with features for blood pressure and weight tracking, as well as storage for recorded EKGs. Additionally, AliveCor offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed EKG readings with healthcare providers. The company also operates KardiaCare, a digital health subscription service that empowers users to manage their heart health conveniently at home. Founded in 2010 and incorporated in 2011, AliveCor is headquartered in Mountain View, California, and is recognized for its innovative contributions to cardiac care through the integration of machine learning techniques.

Insilico Medicine

Series D in 2022
Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Insilico Medicine

Series D in 2022
Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Curebase

Series B in 2022
Curebase is a company that specializes in developing software for clinical trials, aimed at enhancing the efficiency of the clinical research process. Founded in 2017 and based in San Francisco, California, Curebase offers a digital clinical trial assistant that transforms how medical providers discover, activate, and manage clinical trials for patients. The platform reduces recruitment times and automates various manual processes, allowing drug companies to distribute their trials more effectively to clinics. Additionally, it provides comprehensive data access for sponsors, enabling real-time monitoring of trial progress and data management. Curebase serves a diverse clientele, including medical device, biotech, and digital health startups, with a focus on enabling virtual studies and streamlining participant eligibility, enrollment, education, and consent.

Pyka

Series A in 2022
Pyka develops autonomous electric aircraft for agriculture and related applications, including crop-dusting and precision spraying on farms and potential cargo transport. The company designs and manufactures drones and aircraft with autonomous flight controllers and onboard sensors to enable safe, efficient operation over varied terrain. Its fully electric aircraft aim to reduce environmental impact while improving safety, affordability, and accessibility in aviation. Founded in 2016 and based in Oakland, California.

Crowdz

Convertible Note in 2022
Crowdz specializes in modernizing trade finance through its invoicing software. It automates risk rating of receivables, enabling funders to make informed decisions quickly. With over $4 billion auto-risk rated and $93 million financed, Crowdz serves clients like Citibank and Meta, backed by investors such as Techstars Ventures.

Verana Networks

Series B in 2022
Founded in 2019, Verana Networks specializes in developing innovative 5G Radio Access Network solutions for service providers who have licensed millimeter wave spectrum. Its focus is on enabling high-speed and high-capacity 5G services to drive new applications and revenue growth.

Rugged Robotics

Series A in 2022
Rugged Robotics Inc. is a Houston-based company founded in 2018 that specializes in developing robotic platforms tailored for the commercial construction industry. The company focuses on intelligent automation technologies designed to enhance productivity and efficiency on construction sites. One of its key products, the Mark I, marks architectural and engineering designs directly onto concrete floors, thereby assisting construction workers with precise layout tasks. This robotic solution not only replaces traditional manual methods, which are often slow and prone to errors, but also offers a layout-as-a-service model, enabling contractors to access these technologies without significant upfront investment. Through its innovative hardware-enabled solutions, Rugged Robotics addresses specific challenges within the construction sector, ultimately saving time and reducing costs for contractors.

ParkourSC

Venture Round in 2022
ParkourSC is a logistics and supply chain company that delivers a cloud‑based sensor platform for real‑time visibility of assets in motion. The platform creates a digital twin of the supply chain, processing billions of events per second to provide continuous insight into location, condition, timing, and utilization. By collecting data from any source, it enables predictive analytics that detect anomalies and forecast disruptions before they occur. Founded in 2014 and headquartered in Milpitas, California, the company serves manufacturing and pharmaceutical sectors with diagnostic and actionable intelligence.

Gameto

Series A in 2022
Gameto is a biotechnology company focused on advancing female reproductive health through innovative therapies. Recognizing the significant lack of treatment options in this underserved area, Gameto employs cutting-edge scientific techniques to develop solutions that enhance the quality of life for women. The company utilizes cellular engineering to create a platform that produces engineered ovarian and endometrial cell lines capable of mimicking the functions of natural cells, including hormone production and response. This platform underpins a portfolio of cellular therapeutics aimed at addressing various female reproductive diseases. Gameto's first initiative, Fertilo, targets improvements in in vitro fertilization (IVF) and egg freezing processes, striving to make them shorter, safer, and more effective. Additionally, the company is developing Deovo, an organoid model of the female reproductive system, and Ameno, a cell-based therapy designed to mitigate health issues related to primary ovarian insufficiency and menopause. Through these efforts, Gameto aims to transform the landscape of female reproductive health care.

Viome Life Sciences

Series C in 2021
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.

MagicCube

Series C in 2021
MagicCube develops and operates a software platform that secures data exchange between devices and the cloud, embedding into applications used for banking and shopping to protect digital transactions across devices, hardware or operating systems. It positions itself in the software defined trust category with a trusted execution environment based platform that enables large scale deployment and management of IoT and mobile secure solutions for consumers, and provides a payment acceptance platform that turns any mobile or smart device into a secure point of sale terminal with tokenization and encryption, compliant with major card networks, and with remote updates to address evolving security needs, helping merchants improve customer experience.

Meru Health

Series B in 2021
Founded in 2015, Meru Health develops a digital therapeutic program for individuals experiencing stress, depression, anxiety, and other mental health issues. The program, delivered via mobile app, combines licensed clinician support with cognitive behavioral therapy, sleep coaching, and nutrition guidance to improve mental well-being.

Elevian

Series A in 2021
Founded in 2017, Elevian is a biotechnology company dedicated to developing regenerative medicines. It focuses on restoring the body's natural repair mechanisms to prevent and treat age-related diseases such as stroke recovery, Alzheimer's disease, coronary artery disease, and Type 2 diabetes.

Curebase

Series A in 2021
Curebase is a company that specializes in developing software for clinical trials, aimed at enhancing the efficiency of the clinical research process. Founded in 2017 and based in San Francisco, California, Curebase offers a digital clinical trial assistant that transforms how medical providers discover, activate, and manage clinical trials for patients. The platform reduces recruitment times and automates various manual processes, allowing drug companies to distribute their trials more effectively to clinics. Additionally, it provides comprehensive data access for sponsors, enabling real-time monitoring of trial progress and data management. Curebase serves a diverse clientele, including medical device, biotech, and digital health startups, with a focus on enabling virtual studies and streamlining participant eligibility, enrollment, education, and consent.

Docbot

Series A in 2021
DocBot, Inc. is an artificial intelligence technology company based in Irvine, California, specializing in gastrointestinal diseases. The company develops web-based applications for iOS and Android devices that serve as a clinical decision support system, aggregating patient information and providing cloud analytics to healthcare professionals. Its flagship product is built on the UltivisionAI software platform, which offers real-time image analysis, automated reporting, and analytical tools aimed at enhancing patient care and clinical workflows. By integrating various data sources from imaging systems to pathology requisitions, DocBot's platform aids physicians in detecting colorectal cancer and other gastrointestinal conditions, ultimately striving to improve healthcare outcomes and reduce patient risks.

Chef Robotics

Seed Round in 2021
Chef Robotics is a robotics and artificial intelligence company serving the food industry, founded in 2019 and headquartered in San Francisco. It develops AI-enabled robotic automation for food manufacturing, integrating modular hardware and adaptive software with computer vision to handle variability in food products, automate assembly processes, and optimize labor productivity. Its solutions aim to reduce waste, improve consistency, and address workforce shortages through intelligent automation.

SeQure DX

Venture Round in 2021
SeQure DX is a biotechnology company specializing in genomics diagnostics for CRISPR-based gene editing therapies. It develops technologies that identify potential off-target sites prior to therapy initiation, ensuring comprehensive confirmation of actual edits. This enables safer and more effective gene editing therapeutics development, benefiting both researchers and patients.

Bionaut Labs

Series A in 2021
Founded in 2016, Bionaut Labs specializes in developing intra-tissue navigation platforms using micro-robots for precise anatomical targeting. Its innovative technology enables remote-controlled delivery of therapeutics to challenging clinical settings, revolutionizing the treatment of central nervous system disorders and other diseases.

Mighty Buildings

Series B in 2021
Founded in 2017, Mighty Buildings is a pioneering construction technology company based in San Francisco. It specializes in manufacturing custom houses using proprietary 3D printing techniques, aiming to revolutionize the residential housing market by reducing waste and enhancing energy efficiency.

Crowdz

Series A in 2020
Crowdz specializes in modernizing trade finance through its invoicing software. It automates risk rating of receivables, enabling funders to make informed decisions quickly. With over $4 billion auto-risk rated and $93 million financed, Crowdz serves clients like Citibank and Meta, backed by investors such as Techstars Ventures.

Elevian

Venture Round in 2020
Founded in 2017, Elevian is a biotechnology company dedicated to developing regenerative medicines. It focuses on restoring the body's natural repair mechanisms to prevent and treat age-related diseases such as stroke recovery, Alzheimer's disease, coronary artery disease, and Type 2 diabetes.

AliveCor

Series E in 2020
AliveCor, Inc. specializes in developing digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile technology. The company's flagship product, KardiaMobile, is a personal mobile EKG device that provides instant detection of common heart arrhythmias, along with features for blood pressure and weight tracking, as well as storage for recorded EKGs. Additionally, AliveCor offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed EKG readings with healthcare providers. The company also operates KardiaCare, a digital health subscription service that empowers users to manage their heart health conveniently at home. Founded in 2010 and incorporated in 2011, AliveCor is headquartered in Mountain View, California, and is recognized for its innovative contributions to cardiac care through the integration of machine learning techniques.

Solarea Bio

Series A in 2020
Solarea Bio is a biotechnology company that develops microbial therapeutics derived from healthy food sources. It uses computational approaches to create synergistic combinations of bacteria, fungi, and prebiotic fibers with anti-inflammatory properties, targeting chronic health conditions such as osteopenia and osteoporosis in postmenopausal women.

Symbiome

Venture Round in 2020
Symbiome, Inc. is a skincare company based in San Francisco, California, that develops and sells products formulated with microbiomic and plant-based ingredients. Founded in 2017, the company aims to provide effective skincare solutions using scientifically and intentionally formulated ancestral ingredients, eschewing modern chemical additives. By focusing on natural formulations, Symbiome seeks to enhance skin clarity, vibrance, and resilience, offering customers organic alternatives for their skincare needs. The company, which was formerly known as Persona Biome, Inc., rebranded in December 2019 to reflect its commitment to holistic and nature-inspired skincare.

Deep Longevity

Series A in 2020
Deep Longevity, Inc. is a biotechnology company focused on developing innovative solutions for aging and longevity. Founded in 2016 and based in Hong Kong, the company specializes in creating aging and longevity clocks tailored for preventative medicine organizations, health clubs, insurance companies, and aging centers. Its offerings include Longevity Cloud, a platform that hosts deep aging clocks, and Young.AI, a web and mobile application designed to support longevity initiatives. Deep Longevity also develops multifactorial tools known as deep aging clocks to measure biological age, alongside a recommendation engine aimed at suggesting longevity interventions. The company employs advanced AI techniques to harness various data types, including clinical blood tests and other biological metrics, to enhance the accuracy of biological age predictions.

Proprio

Series A in 2020
Proprio, Inc. is a healthcare technology company based in Seattle, Washington, that focuses on developing an advanced surgical navigation and imaging platform. Founded in 2016, the company utilizes machine learning, artificial intelligence, and mixed-reality user interfaces to enhance surgical accuracy and simplify workflows, ultimately improving patient outcomes. Proprio's innovative solutions aim to replace traditional surgical microscopes and navigation systems with a more integrated system that leverages networked camera arrays, depth-sensing technology, and computer graphics. By synthesizing data from multiple inputs, Proprio enables medical professionals to navigate complex anatomical structures in real-time 3D environments, fostering a shift in medicine that embraces modern technological advancements. The company's vision extends beyond mere replacement of existing tools; it seeks to transform the surgical landscape by integrating software and data-driven approaches, enhancing the collaboration between humans and machines in the operating room.

MagicCube

Series B in 2020
MagicCube develops and operates a software platform that secures data exchange between devices and the cloud, embedding into applications used for banking and shopping to protect digital transactions across devices, hardware or operating systems. It positions itself in the software defined trust category with a trusted execution environment based platform that enables large scale deployment and management of IoT and mobile secure solutions for consumers, and provides a payment acceptance platform that turns any mobile or smart device into a secure point of sale terminal with tokenization and encryption, compliant with major card networks, and with remote updates to address evolving security needs, helping merchants improve customer experience.

Gali Health

Seed Round in 2020
Gali Health, Inc. is a health technology company based in San Francisco, California, founded in 2015. The company has developed a mobile application called Gali, which serves as a personal health assistant aimed at individuals with chronic conditions. Gali leverages collective intelligence and artificial intelligence to analyze health data, providing users with personalized support regarding medical, lifestyle, and psychological aspects of managing their health. The platform focuses on empowering users by crowdsourcing health information and delivering medically-validated insights, enabling proactive health management. Gali Health's mission is to ensure that individuals dealing with chronic illnesses do not feel isolated or powerless, advancing consumer-driven healthcare through innovative technology.

Meru Health

Series A in 2020
Founded in 2015, Meru Health develops a digital therapeutic program for individuals experiencing stress, depression, anxiety, and other mental health issues. The program, delivered via mobile app, combines licensed clinician support with cognitive behavioral therapy, sleep coaching, and nutrition guidance to improve mental well-being.

Chef Robotics

Seed Round in 2020
Chef Robotics is a robotics and artificial intelligence company serving the food industry, founded in 2019 and headquartered in San Francisco. It develops AI-enabled robotic automation for food manufacturing, integrating modular hardware and adaptive software with computer vision to handle variability in food products, automate assembly processes, and optimize labor productivity. Its solutions aim to reduce waste, improve consistency, and address workforce shortages through intelligent automation.

Pyka

Seed Round in 2019
Pyka develops autonomous electric aircraft for agriculture and related applications, including crop-dusting and precision spraying on farms and potential cargo transport. The company designs and manufactures drones and aircraft with autonomous flight controllers and onboard sensors to enable safe, efficient operation over varied terrain. Its fully electric aircraft aim to reduce environmental impact while improving safety, affordability, and accessibility in aviation. Founded in 2016 and based in Oakland, California.

GuRu

Series A in 2019
GuRu Wireless, Inc. enables safe, effective and customizable transmission of power over-the-air using proprietary millimeter-wave (mmWave) integrated circuits, modules and proprietary Smart RF Lensing technology. A miniature-sized power transfer system delivers power at an unprecedented distance efficiently and with precision. GuRu's wireless solution can be used as a charging hub or a power source in many settings where access to an energy source is needed. It is easy to install, safe, and sophisticated enough to find and adjust for various power levels to sync with the needs of any device. Even during use, it continuously charges devices and as a safety measure, reroutes power as necessary. Founded in 2017 by a team of scientists and engineers from Caltech, GuRu aims to ensure access to power be as ubiquitous as WiFi.

Metawave

Series A in 2019
Metawave Corporation is a technology company based in Palo Alto, California, specializing in the development of advanced beamsteering radars using metamaterials and artificial intelligence. Founded in 2017, the company primarily serves the automotive industry, offering innovative solutions for safe automated driving. Its flagship product, SPEKTRA, is designed to enhance safety for automakers by providing high-performance radar capabilities for 3D imaging and vehicle-to-vehicle communications. Additionally, Metawave develops TURBO active repeaters to extend signal coverage in difficult environments, as well as ECHO passive reflectors to optimize signal direction in areas with lower coverage. The company also offers AWARE, an AI platform that leverages deep learning to extract valuable information from radar signals. In parallel, Metawave is working on smart beamsteering antennas to improve 4G and 5G networks, aiming to enhance connectivity for billions of users.

Insilico Medicine

Series B in 2019
Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

ParkourSC

Series B in 2019
ParkourSC is a logistics and supply chain company that delivers a cloud‑based sensor platform for real‑time visibility of assets in motion. The platform creates a digital twin of the supply chain, processing billions of events per second to provide continuous insight into location, condition, timing, and utilization. By collecting data from any source, it enables predictive analytics that detect anomalies and forecast disruptions before they occur. Founded in 2014 and headquartered in Milpitas, California, the company serves manufacturing and pharmaceutical sectors with diagnostic and actionable intelligence.

Mighty Buildings

Series A in 2019
Founded in 2017, Mighty Buildings is a pioneering construction technology company based in San Francisco. It specializes in manufacturing custom houses using proprietary 3D printing techniques, aiming to revolutionize the residential housing market by reducing waste and enhancing energy efficiency.

Gallant Pet

Series A in 2019
Gallant Pet, Inc. is a pet service company based in San Diego, California, that specializes in stem cell preservation services for pets. Founded in 2018 by Aaron Hirschhorn, the company collects and banks stem cells from tissue during routine spay or neuter procedures. Gallant Pet also provides a platelet-rich plasma (PRP) kit for treatment of dogs suffering from osteoarthritis or other musculoskeletal conditions. In addition to its preservation services, Gallant Pet is involved in clinical research to develop effective stem cell therapies for pets. The company's focus on retrieving and preserving regenerative cells allows pet owners to utilize their pets' young stem cells for potential treatments when needed.

Gali Health

Seed Round in 2019
Gali Health, Inc. is a health technology company based in San Francisco, California, founded in 2015. The company has developed a mobile application called Gali, which serves as a personal health assistant aimed at individuals with chronic conditions. Gali leverages collective intelligence and artificial intelligence to analyze health data, providing users with personalized support regarding medical, lifestyle, and psychological aspects of managing their health. The platform focuses on empowering users by crowdsourcing health information and delivering medically-validated insights, enabling proactive health management. Gali Health's mission is to ensure that individuals dealing with chronic illnesses do not feel isolated or powerless, advancing consumer-driven healthcare through innovative technology.

Viome Life Sciences

Series B in 2019
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.

Mojo Vision

Series B in 2019
Founded in 2015, Mojo Vision specializes in developing and commercializing advanced micro-LED display technology for various applications. The company is renowned for creating the world's smallest dynamic display for augmented reality smart contact lenses. Headquartered in Saratoga, California, Mojo Vision aims to disrupt the $160 billion display industry with its proprietary quantum-dot technology.

Docbot

Seed Round in 2019
DocBot, Inc. is an artificial intelligence technology company based in Irvine, California, specializing in gastrointestinal diseases. The company develops web-based applications for iOS and Android devices that serve as a clinical decision support system, aggregating patient information and providing cloud analytics to healthcare professionals. Its flagship product is built on the UltivisionAI software platform, which offers real-time image analysis, automated reporting, and analytical tools aimed at enhancing patient care and clinical workflows. By integrating various data sources from imaging systems to pathology requisitions, DocBot's platform aids physicians in detecting colorectal cancer and other gastrointestinal conditions, ultimately striving to improve healthcare outcomes and reduce patient risks.

Iota Biosciences

Series A in 2018
Founded in 2017, Iota Biosciences develops innovative bioelectronics technology for medical applications. The company focuses on creating safe and effective diagnostic and therapeutic devices, with a particular emphasis on wireless neural recording technologies for treating immune and neural disorders.

Octi

Seed Round in 2018
Octi is the world’s first augmented reality social platform where reality merges with the metaverse and empowers anyone to create vibrant content with digital objects and scenes, rewarding creators with virtual and physical goods from leading brands. Octi’s independent Los Angeles-based team builds and combines the latest in machine learning, computer vision, and AR technologies to deliver the killer applications of the future.

Insilico Medicine

Series A in 2018
Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Oura

Series A in 2018
Oura is a Finnish company that specializes in the development of a smart wellness ring designed to monitor and track various biometric data related to health and well-being. The ring incorporates advanced sensors to measure key metrics such as heart rate, sleep cycles, and activity levels, providing users with insights into their physiological and behavioral responses to sleep, rest, and recovery. This data is accessible through the accompanying Oura application, which enables users to understand their overall health status and make informed lifestyle choices. Oura operates within the health and wellness industry, focusing on enhancing the user's understanding of their body and promoting better health outcomes.

IVIVA

Seed Round in 2018
IVIVA Medical, Inc. is a biotechnology company based in Beverly, Massachusetts, focused on developing innovative therapies for end-stage renal disease (ESRD). Founded in 2013, the company aims to address the critical shortage of donor organs by creating autologous tissue constructs that provide alternative treatments for patients suffering from this condition, which affects over 500,000 individuals in the United States. IVIVA Medical leverages advanced technologies in tissue engineering, 3D additive manufacturing, and stem cell biology to create bioartificial platforms and systems. These platforms not only facilitate therapeutic applications but also serve as essential building blocks for the next generation of engineered, functionalized tissues, positioning IVIVA Medical at the forefront of regenerative medicine and enhancing the capacity of medical professionals to manage end-stage kidney disease.

Synadia Communications

Seed Round in 2018
Synadia Communications develops and maintains NATS.io, an open-source messaging system designed for cloud-native applications, microservices architectures, IoT, and other distributed systems. Founded in 2017, the company offers commercial support, consulting services, and training around its technology.

Elevian

Convertible Note in 2018
Founded in 2017, Elevian is a biotechnology company dedicated to developing regenerative medicines. It focuses on restoring the body's natural repair mechanisms to prevent and treat age-related diseases such as stroke recovery, Alzheimer's disease, coronary artery disease, and Type 2 diabetes.

Exo

Series A in 2017
Exo is a medical device startup specializing in handheld ultrasound technology. It combines advanced materials, sensors, signal processing, and computation with semiconductor manufacturing economies to deliver affordable, high-quality imaging. This empowers healthcare professionals to make critical real-time decisions, enhancing patient outcomes.

Atomiton

Seed Round in 2017
Atomiton is a developer of industrial software aimed at transforming and optimizing operations on a global scale. The company's platform utilizes artificial intelligence and machine learning to enhance operational efficiencies and conduct real-time industrial analytics. By offering insights into carbon emissions and energy consumption, Atomiton enables businesses to monitor and improve their sustainability metrics. This capability allows organizations to reduce costs while simultaneously minimizing their operational energy, water, and carbon intensity, ultimately supporting their goals for sustainability and efficiency.

Dreamscape Immersive

Series B in 2017
Founded in 2016, Dreamscape Immersive specializes in location-based virtual reality software, combining cinematic storytelling with theme park ride thrills. It offers immersive VR experiences at locations worldwide.

ParkourSC

Series A in 2017
ParkourSC is a logistics and supply chain company that delivers a cloud‑based sensor platform for real‑time visibility of assets in motion. The platform creates a digital twin of the supply chain, processing billions of events per second to provide continuous insight into location, condition, timing, and utilization. By collecting data from any source, it enables predictive analytics that detect anomalies and forecast disruptions before they occur. Founded in 2014 and headquartered in Milpitas, California, the company serves manufacturing and pharmaceutical sectors with diagnostic and actionable intelligence.

GuRu

Seed Round in 2017
GuRu Wireless, Inc. enables safe, effective and customizable transmission of power over-the-air using proprietary millimeter-wave (mmWave) integrated circuits, modules and proprietary Smart RF Lensing technology. A miniature-sized power transfer system delivers power at an unprecedented distance efficiently and with precision. GuRu's wireless solution can be used as a charging hub or a power source in many settings where access to an energy source is needed. It is easy to install, safe, and sophisticated enough to find and adjust for various power levels to sync with the needs of any device. Even during use, it continuously charges devices and as a safety measure, reroutes power as necessary. Founded in 2017 by a team of scientists and engineers from Caltech, GuRu aims to ensure access to power be as ubiquitous as WiFi.

Metawave

Seed Round in 2017
Metawave Corporation is a technology company based in Palo Alto, California, specializing in the development of advanced beamsteering radars using metamaterials and artificial intelligence. Founded in 2017, the company primarily serves the automotive industry, offering innovative solutions for safe automated driving. Its flagship product, SPEKTRA, is designed to enhance safety for automakers by providing high-performance radar capabilities for 3D imaging and vehicle-to-vehicle communications. Additionally, Metawave develops TURBO active repeaters to extend signal coverage in difficult environments, as well as ECHO passive reflectors to optimize signal direction in areas with lower coverage. The company also offers AWARE, an AI platform that leverages deep learning to extract valuable information from radar signals. In parallel, Metawave is working on smart beamsteering antennas to improve 4G and 5G networks, aiming to enhance connectivity for billions of users.

Pyka

Pre Seed Round in 2017
Pyka develops autonomous electric aircraft for agriculture and related applications, including crop-dusting and precision spraying on farms and potential cargo transport. The company designs and manufactures drones and aircraft with autonomous flight controllers and onboard sensors to enable safe, efficient operation over varied terrain. Its fully electric aircraft aim to reduce environmental impact while improving safety, affordability, and accessibility in aviation. Founded in 2016 and based in Oakland, California.

MagicCube

Series A in 2017
MagicCube develops and operates a software platform that secures data exchange between devices and the cloud, embedding into applications used for banking and shopping to protect digital transactions across devices, hardware or operating systems. It positions itself in the software defined trust category with a trusted execution environment based platform that enables large scale deployment and management of IoT and mobile secure solutions for consumers, and provides a payment acceptance platform that turns any mobile or smart device into a secure point of sale terminal with tokenization and encryption, compliant with major card networks, and with remote updates to address evolving security needs, helping merchants improve customer experience.

Viome Life Sciences

Series A in 2017
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.

Exo

Venture Round in 2017
Exo is a medical device startup specializing in handheld ultrasound technology. It combines advanced materials, sensors, signal processing, and computation with semiconductor manufacturing economies to deliver affordable, high-quality imaging. This empowers healthcare professionals to make critical real-time decisions, enhancing patient outcomes.

Dreamscape Immersive

Series A in 2017
Founded in 2016, Dreamscape Immersive specializes in location-based virtual reality software, combining cinematic storytelling with theme park ride thrills. It offers immersive VR experiences at locations worldwide.

DigiLens

Series B in 2017
DigiLens Inc. is a technology company based in Sunnyvale, California, specializing in holographic waveguide display solutions for extended reality (XR) applications. Founded in 1997 and formerly known as SBG Labs, DigiLens has developed a patented optical platform and photopolymer technology that enables original equipment manufacturers (OEMs) to create customizable XR devices for various sectors, including automotive, enterprise, consumer, avionics, and military. The company offers a range of products, such as the Crystal30 and Crystal50 lenses, which facilitate the design of waveguide-based displays. Additionally, DigiLens provides innovative solutions like the DigiLens AutoHUD, which enhances the field of view of traditional heads-up displays, and CrystalClear, an augmented reality heads-up display. Supporting its offerings, DigiLens also supplies light engines and hardware development kits, such as Insight30, to assist users in developing wearable devices.

Terramera

Venture Round in 2016
Founded in 2009, Terramera develops plant-based pesticides and fertilizers. It offers products like Proof (for bed bugs and dust mites), Actigate (an organic pesticide), and Rango (a plant-based pest control). The company aims to transform agriculture by fusing artificial intelligence, science, and nature to provide sustainable alternatives to chemical pesticides and fertilizers.

Epharmix

Seed Round in 2016
Epharmix, Inc. is a digital healthcare company that specializes in developing clinically validated, condition-specific communication tools designed for the healthcare industry. Founded in 2015 and based in St. Louis, Missouri, the company creates digital interventions tailored to various patient populations, aimed at enhancing patient-physician engagement. Epharmix's products facilitate the automatic collection of clinical data over time, which allows for algorithmic alerts to healthcare providers, thereby supporting chronic care management for patients. By focusing on underserved patient groups, Epharmix enables care teams to improve healthcare delivery while reducing workload through proven interventions that enhance both engagement and health outcomes.

Meta View

Series B in 2016
Meta View is a technology company specializing in augmented and virtual reality solutions, catering to various industries such as manufacturing, communication, media, medicine, education, and 3D modeling. Founded in 2019 by Ben Sand, Meron Gribetz, and Raymond Lo, the company develops wearable devices and development kits, including the Meta 1 and Meta 2, which enable users to interact with holograms and access digital information seamlessly. Headquartered in San Mateo, California, Meta View distributes its products to markets in the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Singapore, Taiwan, and throughout the European Union and EFTA. The company's innovative offerings leverage machine learning and artificial intelligence to enhance user experiences in both augmented and virtual reality environments.

Terramera

Venture Round in 2016
Founded in 2009, Terramera develops plant-based pesticides and fertilizers. It offers products like Proof (for bed bugs and dust mites), Actigate (an organic pesticide), and Rango (a plant-based pest control). The company aims to transform agriculture by fusing artificial intelligence, science, and nature to provide sustainable alternatives to chemical pesticides and fertilizers.

Singularity University

Series A in 2016
Singularity University, officially known as Singularity Education Group, is a benefit corporation based in Santa Clara, California, founded in 2008. It operates as a learning and innovation community that collaborates with entrepreneurs, corporations, nonprofits, governments, investors, and academic institutions. The organization provides a range of educational programs, including executive and exponential innovation programs, an incubator, and a global startup program. Its offerings encompass online courses focused on exponential thinking and behavioral transformation, as well as international summits and events aimed at fostering collaboration and innovation. Singularity University aims to equip individuals and organizations with the knowledge and tools to leverage advanced technologies such as artificial intelligence, robotics, and biotechnology to address significant global challenges like education, health, and environmental sustainability. Through its global network, which includes numerous chapters and alumni, Singularity University seeks to inspire and empower individuals to create impactful solutions that benefit humanity.

BlueDot

Series A in 2016
BlueDot identifies and nurtures innovative technologies from NASA and national labs, pairing them with skilled entrepreneurs. Their mission is to create companies that address global challenges and improve lives.

BlueLine Grid

Venture Round in 2016
BlueLine Grid, Inc. is a provider of mobile solutions that connects law enforcement, first responders, security teams, and government agencies across the United States. Founded in 2013 and headquartered in Annapolis, Maryland, the company offers a suite of secure communication tools designed to meet the needs of public and private security officials. Its flagship product, GridTeam, is a mobile application that allows users to locate and connect with one another based on area, organization, proximity, or specialty. Additionally, BlueLine Grid features a Grid bot for Microsoft Skype, enabling mass notification services and group conferencing directly from Skype messages. The company's services prioritize security and privacy, catering to the collaboration needs of demanding government agencies and leading corporations.

CloudMondo

Venture Round in 2016
CloudMondo is a technology startup based in Silicon Valley that operates an online marketplace for Over-The-Top (OTT) network services. The company aims to make internet connectivity a fundamental right by providing a cloud-based platform designed to offer disruptively affordable broadband access. Its patent-pending platform utilizes artificial intelligence, open-source technologies, virtualization, and software-defined networking to significantly lower the costs and complexities associated with delivering reliable internet services. CloudMondo also offers a suite of high-value OTT services that can be tailored for various stakeholders, including municipalities, venue owners, service providers, and businesses, enabling them to generate revenue while enhancing broadband access for their users. The platform has successfully entered production and is currently operational in twelve countries across four continents, reflecting its commitment to improving global internet accessibility.

Kindred AI

Series A in 2015
Kindred's mission is to build machines with human-like intelligence. Since its founding in 2014, Kindred has been exploring and engineering systems that enable robots to interact with the physical world, fulfilling the goal of bringing humans and intelligent machines together to solve real-world problems. Kindred has built an AI platform that integrates vision, grasping and placement to create autonomous solutions for complex commercial problems. With increased labor complexities in e-commerce fulfillment centers, Kindred developed a flagship product, SORT, to help retailers stay competitive. Kindred smart piece-picking SORT robots tackle a labor intensive part of the supply chain, which is Putwall Sortation, completing the manual task to pick and place items into separate customer orders. Kindred robots are currently in commercial use at e-commerce leaders including Gap, Inc., Carter’s and other global retailers. The Kindred SORT robots work alongside warehouse staff to quickly and accurately sort items into individual customer orders. Kindred has offices in San Francisco & Toronto.

Meta View

Series A in 2015
Meta View is a technology company specializing in augmented and virtual reality solutions, catering to various industries such as manufacturing, communication, media, medicine, education, and 3D modeling. Founded in 2019 by Ben Sand, Meron Gribetz, and Raymond Lo, the company develops wearable devices and development kits, including the Meta 1 and Meta 2, which enable users to interact with holograms and access digital information seamlessly. Headquartered in San Mateo, California, Meta View distributes its products to markets in the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Singapore, Taiwan, and throughout the European Union and EFTA. The company's innovative offerings leverage machine learning and artificial intelligence to enhance user experiences in both augmented and virtual reality environments.

ParkourSC

Seed Round in 2014
ParkourSC is a logistics and supply chain company that delivers a cloud‑based sensor platform for real‑time visibility of assets in motion. The platform creates a digital twin of the supply chain, processing billions of events per second to provide continuous insight into location, condition, timing, and utilization. By collecting data from any source, it enables predictive analytics that detect anomalies and forecast disruptions before they occur. Founded in 2014 and headquartered in Milpitas, California, the company serves manufacturing and pharmaceutical sectors with diagnostic and actionable intelligence.

AliveCor

Series B in 2012
AliveCor, Inc. specializes in developing digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile technology. The company's flagship product, KardiaMobile, is a personal mobile EKG device that provides instant detection of common heart arrhythmias, along with features for blood pressure and weight tracking, as well as storage for recorded EKGs. Additionally, AliveCor offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed EKG readings with healthcare providers. The company also operates KardiaCare, a digital health subscription service that empowers users to manage their heart health conveniently at home. Founded in 2010 and incorporated in 2011, AliveCor is headquartered in Mountain View, California, and is recognized for its innovative contributions to cardiac care through the integration of machine learning techniques.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.